|
call loadScript javascripts\jsmol\core\package.js call loadScript javascripts\jsmol\core\core.z.js -- required by ClazzNode call loadScript javascripts\jsmol\J\awtjs2d\WebOutputChannel.js Jmol JavaScript applet jmolApplet0_object__4298357260970116__ initializing getValue debug = null getValue logLevel = null getValue allowjavascript = null AppletRegistry.checkIn(jmolApplet0_object__4298357260970116__) call loadScript javascripts\jsmol\core\corestate.z.js viewerOptions: { "name":"jmolApplet0_object","applet":true,"documentBase":"https://www.ebi.ac.uk/chebi/searchId.do;jsessionid=BD6CAFFA66AA0E41E1037DF9AB963686?chebiId=CHEBI:8809","platform":"J.awtjs2d.Platform","fullName":"jmolApplet0_object__4298357260970116__","display":"jmolApplet0_canvas2d","signedApplet":"true","appletReadyCallback":"Jmol._readyCallback","statusListener":"[J.appletjs.Jmol.MyStatusListener object]","codeBase":"https://www.ebi.ac.uk/chebi/javascripts/jsmol/","syncId":"4298357260970116","bgcolor":"#000" } (C) 2012 Jmol Development Jmol Version: 13.2.7 $Date: 2013-10-01 11:35:15 -0500 (Tue, 01 Oct 2013) $ java.vendor: j2s java.version: 0.0 os.name: j2s Access: ALL memory: 0.0/0.0 processors available: 1 useCommandThread: false appletId:jmolApplet0_object (signed) starting HoverWatcher_1 getValue emulate = null defaults = "Jmol" getValue boxbgcolor = null getValue bgcolor = #000 backgroundColor = "#000" getValue ANIMFRAMECallback = null getValue APPLETREADYCallback = Jmol._readyCallback APPLETREADYCallback = "Jmol._readyCallback" getValue ATOMMOVEDCallback = null getValue CLICKCallback = null getValue ECHOCallback = null getValue ERRORCallback = null getValue EVALCallback = null getValue HOVERCallback = null getValue LOADSTRUCTCallback = null getValue MEASURECallback = null getValue MESSAGECallback = null getValue MINIMIZATIONCallback = null getValue PICKCallback = null getValue RESIZECallback = null getValue SCRIPTCallback = null getValue SYNCCallback = null getValue STRUCTUREMODIFIEDCallback = null getValue doTranslate = null language=en_US getValue popupMenu = null getValue script = null Jmol applet jmolApplet0_object__4298357260970116__ ready call loadScript javascripts\jsmol\core\corescript.z.js call loadScript javascripts\jsmol\J\script\FileLoadThread.js starting QueueThread0_2 script 1 started starting HoverWatcher_3 starting HoverWatcher_4 The Resolver thinks Mol 6EU - Ideal conformer RDKit 3D starting HoverWatcher_5 Time for openFile(6EU - Ideal conformer RDKit 3D 86 92 0 0 0 0 0 0 0 0999 V2000 7.9870 -0.0940 2.8100 C 0 0 0 0 0 0 0 0 0 0 0 0 8.5140 -0.1760 1.4850 O 0 0 0 0 0 0 0 0 0 0 0 0 7.6290 -0.0580 0.4600 C 0 0 0 0 0 0 0 0 0 0 0 0 6.2820 0.1330 0.7240 C 0 0 0 0 0 0 0 0 0 0 0 0 8.0740 -0.1230 -0.8580 C 0 0 0 0 0 0 0 0 0 0 0 0 9.3960 -0.3050 -1.1220 O 0 0 0 0 0 0 0 0 0 0 0 0 7.1680 -0.0020 -1.8990 C 0 0 0 0 0 0 0 0 0 0 0 0 5.8250 0.1830 -1.6280 C 0 0 0 0 0 0 0 0 0 0 0 0 5.3830 0.2530 -0.3200 C 0 0 0 0 0 0 0 0 0 0 0 0 3.9180 0.4540 -0.0310 C 0 0 0 0 0 0 0 0 0 0 0 0 3.2380 -0.8860 0.0760 C 0 0 0 0 0 0 0 0 0 0 0 0 3.8780 -1.9010 -0.0680 O 0 0 0 0 0 0 0 0 0 0 0 0 1.9220 -0.9530 0.3310 O 0 0 0 0 0 0 0 0 0 0 0 0 1.3340 -2.2770 0.4210 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.1400 -2.1540 0.7100 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.6100 -0.9690 0.8200 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.0330 -0.5900 1.1090 C 0 0 2 0 0 0 0 0 0 0 0 0 -0.9080 -3.4190 0.8360 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.3210 -3.3170 0.3420 C 0 0 2 0 0 0 0 0 0 0 0 0 -3.1730 -3.1300 1.4730 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.7890 -4.5700 -0.3720 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.5690 -5.7200 -0.0420 O 0 0 0 0 0 0 0 0 0 0 0 0 -3.5590 -4.1180 -1.5350 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.3400 -5.0320 -2.4450 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.4620 -2.7960 -1.7120 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.5490 -2.2180 -0.6740 C 0 0 1 0 0 0 0 0 0 0 0 0 -2.9080 -0.8570 -0.1280 C 0 0 2 0 0 0 0 0 0 0 0 0 -2.6390 0.1230 -1.1310 O 0 0 0 0 0 0 0 0 0 0 0 0 -4.3600 -0.7800 0.3360 C 0 0 2 0 0 0 0 0 0 0 0 0 -5.3090 -0.6990 -0.8690 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.6110 0.4630 1.1610 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.4920 1.4660 1.2080 C 0 0 2 0 0 0 0 0 0 0 0 0 -3.7650 2.4970 2.2680 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.9890 3.7420 1.9280 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.7820 2.0980 3.7210 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.4920 2.0850 -0.1150 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.0750 0.9280 1.3620 C 0 0 2 0 0 0 0 0 0 0 0 0 -1.3390 1.4970 0.2410 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.3700 1.4710 -0.7760 C 0 0 1 0 0 0 0 0 0 0 0 0 -1.9470 2.2790 -2.0050 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.5710 3.6760 -1.5820 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.2650 3.9640 -1.2300 C 0 0 0 0 0 0 0 0 0 0 0 0 0.0790 5.2450 -0.8420 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.8810 6.2380 -0.8060 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.1860 5.9510 -1.1580 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.5300 4.6710 -1.5520 C 0 0 0 0 0 0 0 0 0 0 0 0 7.5040 0.8730 2.9500 H 0 0 0 0 0 0 0 0 0 0 0 0 7.2560 -0.8890 2.9610 H 0 0 0 0 0 0 0 0 0 0 0 0 8.7970 -0.2040 3.5310 H 0 0 0 0 0 0 0 0 0 0 0 0 5.9350 0.1880 1.7450 H 0 0 0 0 0 0 0 0 0 0 0 0 9.6580 -1.2330 -1.1960 H 0 0 0 0 0 0 0 0 0 0 0 0 7.5110 -0.0520 -2.9210 H 0 0 0 0 0 0 0 0 0 0 0 0 5.1200 0.2770 -2.4410 H 0 0 0 0 0 0 0 0 0 0 0 0 3.8040 0.9960 0.9080 H 0 0 0 0 0 0 0 0 0 0 0 0 3.4640 1.0280 -0.8390 H 0 0 0 0 0 0 0 0 0 0 0 0 1.4770 -2.8030 -0.5240 H 0 0 0 0 0 0 0 0 0 0 0 0 1.8170 -2.8360 1.2230 H 0 0 0 0 0 0 0 0 0 0 0 0 0.0950 -0.1600 0.6960 H 0 0 0 0 0 0 0 0 0 0 0 0 -2.4110 -1.1290 1.9820 H 0 0 0 0 0 0 0 0 0 0 0 0 -0.4000 -4.1940 0.2650 H 0 0 0 0 0 0 0 0 0 0 0 0 -0.9310 -3.7110 1.8840 H 0 0 0 0 0 0 0 0 0 0 0 0 -3.1260 -3.8440 2.1240 H 0 0 0 0 0 0 0 0 0 0 0 0 -4.2390 -6.0610 -2.1010 H 0 0 0 0 0 0 0 0 0 0 0 0 -5.3920 -4.7450 -2.4310 H 0 0 0 0 0 0 0 0 0 0 0 0 -3.9550 -4.9490 -3.4610 H 0 0 0 0 0 0 0 0 0 0 0 0 -3.9490 -2.2530 -2.5100 H 0 0 0 0 0 0 0 0 0 0 0 0 -1.5720 -2.0790 -1.1890 H 0 0 0 0 0 0 0 0 0 0 0 0 -4.6270 -1.6510 0.9290 H 0 0 0 0 0 0 0 0 0 0 0 0 -5.1840 -1.5850 -1.4910 H 0 0 0 0 0 0 0 0 0 0 0 0 -6.3390 -0.6450 -0.5170 H 0 0 0 0 0 0 0 0 0 0 0 0 -5.0780 0.1910 -1.4540 H 0 0 0 0 0 0 0 0 0 0 0 0 -5.4980 0.9550 0.7650 H 0 0 0 0 0 0 0 0 0 0 0 0 -4.8250 0.1450 2.1820 H 0 0 0 0 0 0 0 0 0 0 0 0 -4.1850 4.4830 2.6890 H 0 0 0 0 0 0 0 0 0 0 0 0 -3.9770 4.0280 0.8860 H 0 0 0 0 0 0 0 0 0 0 0 0 -2.7800 2.2010 4.1370 H 0 0 0 0 0 0 0 0 0 0 0 0 -4.4700 2.7440 4.2670 H 0 0 0 0 0 0 0 0 0 0 0 0 -4.1080 1.0620 3.8090 H 0 0 0 0 0 0 0 0 0 0 0 0 -1.6470 1.1960 2.3280 H 0 0 0 0 0 0 0 0 0 0 0 0 -1.0900 1.7990 -2.4770 H 0 0 0 0 0 0 0 0 0 0 0 0 -2.7740 2.3240 -2.7130 H 0 0 0 0 0 0 0 0 0 0 0 0 0.4850 3.1870 -1.2570 H 0 0 0 0 0 0 0 0 0 0 0 0 1.0990 5.4690 -0.5670 H 0 0 0 0 0 0 0 0 0 0 0 0 -0.6120 7.2390 -0.5030 H 0 0 0 0 0 0 0 0 0 0 0 0 -2.9370 6.7270 -1.1300 H 0 0 0 0 0 0 0 0 0 0 0 0 -3.5500 4.4460 -1.8270 H 0 0 0 0 0 0 0 0 0 0 0 0 6 5 1 0 7 5 1 0 7 8 2 0 5 3 2 0 8 9 1 0 1 2 1 0 3 2 1 0 3 4 1 0 9 4 2 0 9 10 1 0 10 11 1 0 35 33 1 0 13 11 1 0 13 14 1 0 11 12 2 0 34 33 2 3 32 33 1 1 14 15 1 0 37 38 1 0 37 32 1 0 37 17 1 0 38 39 1 0 16 15 2 0 16 17 1 0 32 36 1 0 32 31 1 0 15 18 1 0 17 27 1 0 46 45 2 0 46 41 1 0 36 39 1 0 39 40 1 6 39 28 1 0 45 44 1 0 31 29 1 0 40 41 1 0 18 19 1 0 19 20 1 1 41 42 2 0 27 28 1 6 27 29 1 0 27 26 1 0 29 30 1 0 19 26 1 0 19 21 1 0 44 43 2 0 26 25 1 0 42 43 1 0 21 22 2 0 21 23 1 0 25 23 2 0 23 24 1 0 1 47 1 0 1 48 1 0 1 49 1 0 4 50 1 0 6 51 1 0 7 52 1 0 8 53 1 0 10 54 1 0 10 55 1 0 14 56 1 0 14 57 1 0 16 58 1 0 17 59 1 1 18 60 1 0 18 61 1 0 20 62 1 0 24 63 1 0 24 64 1 0 24 65 1 0 25 66 1 0 26 67 1 6 29 68 1 1 30 69 1 0 30 70 1 0 30 71 1 0 31 72 1 0 31 73 1 0 34 74 1 0 34 75 1 0 35 76 1 0 35 77 1 0 35 78 1 0 37 79 1 1 40 80 1 0 40 81 1 0 42 82 1 0 43 83 1 0 44 84 1 0 45 85 1 0 46 86 1 0 M END): 18 ms reading 86 atoms ModelSet: haveSymmetry:false haveUnitcells:false haveFractionalCoord:false 1 model in this collection. Use getProperty "modelInfo" or getProperty "auxiliaryInfo" to inspect them. Default Van der Waals type for model set to Babel 86 atoms created ModelSet: not autobonding; use forceAutobond=true to force automatic bond creation Script completed Jmol script terminated
|
Resiniferatoxin (RTX) is a naturally occurring chemical found in resin spurge (Euphorbia resinifera), a cactus-like plant commonly found in Morocco, and in Euphorbia poissonii found in northern Nigeria. It is a potent functional analog of capsaicin, the active ingredient in chili peppers. |
Read full article at Wikipedia
|
InChI=1S/C37H40O9/c1-21(2)35-17-23(4)37-27(33(35)44-36(45-35,46-37)19-24-9-7-6-8-10-24)14-26(18-34(41)30(37)13-22(3)32(34)40)20-43-31(39)16-25-11-12-28(38)29(15-25)42-5/h6-15,23,27,30,33,38,41H,1,16-20H2,2-5H3/t23-,27+,30-,33-,34-,35-,36-,37-/m1/s1 |
DSDNAKHZNJAGHN-MXTYGGKSSA-N |
C=1(C=C(C(=CC1)O)OC)CC(OCC2=C[C@@]3([C@]4([C@]5([C@](C2)(C(=O)C(=C5)C)O)[H])O[C@]6(O[C@@]([C@@]3(O6)[H])(C(=C)C)C[C@H]4C)CC=7C=CC=CC7)[H])=O |
|
Euphorbia poissonii
(NCBI:txid212962)
|
See:
Book: Harborne, Phytochemical Dictionary Second Edition, Taylor and Francis (1999), Chapter 52.
|
Euphorbia resinifera
(NCBI:txid457265)
|
See:
Book: Harborne, Phytochemical Dictionary Second Edition, Taylor and Francis (1999), Chapter 52.
|
plant metabolite
Any eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
neurotoxin
A poison that interferes with the functions of the nervous system.
analgesic
An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms.
TRPV1 agonist
An agonist at the transient receptor potential vanilloid 1 (TRPV1).
|
|
analgesic
An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms.
|
|
View more via ChEBI Ontology
[(2S,3aR,3bS,6aR,9aR,9bR,10R,11aR)-2-benzyl-6a-hydroxy-8,10-dimethyl-7-oxo-11a-(prop-1-en-2-yl)-3a,6,6a,7,9a,10,11,11a-octahydro-3bH-2,9b-epoxyazuleno[4',5':5,6]benzo[1,2-d][1,3]dioxol-5-yl]methyl (4-hydroxy-3-methoxyphenyl)acetate
|
(+)-resiniferatoxin
|
ChEBI
|
resiniferatoxin
|
KEGG COMPOUND
|
resiniferatoxin
|
UniProt
|
RTX
|
ChemIDplus
|
5371150
|
Reaxys Registry Number
|
Reaxys
|
57444-62-9
|
CAS Registry Number
|
ChemIDplus
|
Darmani NA, Henry DA, Zhong W, Chebolu S (2020) Ultra-low doses of the transient receptor potential vanilloid 1 agonist, resiniferatoxin, prevents vomiting evoked by diverse emetogens in the least shrew (Cryptotis parva). Behavioural pharmacology 31, 3-14 [PubMed:31503071] [show Abstract] Published studies have shown that the transient receptor potential vanilloid 1 (TRPV1) receptor agonist, resiniferatoxin (RTX), has pro and antiemetic effects. RTX can suppress vomiting evoked by a variety of nonselective emetogens such as copper sulfate and cisplatin in several vomit-competent species. In the least shrew, we have already demonstrated that combinations of ultra-low doses of RTX and low doses of the cannabinoid CB1/2 receptor agonist delta-9-tetrahydrocannabinol (Δ-THC) produce additive antiemetic effects against cisplatin-evoked vomiting. In the current study, we investigated the broad-spectrum antiemetic potential of very low nonemetic doses of RTX against a diverse group of specific emetogens including selective and nonselective agonists of serotonergic 5-hydroxytrptamine (5-HT3) receptor (5-HT and 2-Me-5-HT), dopaminergic D2 receptor (apomorphine and quinpirole), cholinergic M1 receptor (pilocarpine and McN-A-343), as well as the selective substance P neurokinin NK1 receptor agonist GR73632, the selective L-Type calcium channel agonist FPL64176, and the sarcoplasmic endoplasmic reticulum calcium ATPase (SERCA) inhibitor thapsigargin. When administered subcutaneously, ultra-low (0.01 µg/kg) to low (5.0 µg/kg) doses of RTX suppressed vomiting induced by the aforementioned emetogens in a dose-dependent fashion with 50% inhibitory dose values ranging from 0.01 to 1.26 µg/kg. This study is the first to demonstrate that low nanomolar nonemetic doses of RTX have the capacity to completely abolish vomiting caused by diverse receptor specific emetogens in the least shrew model of emesis. | Wu Y, Hu Z, Wang D, Lv K, Hu N (2020) Resiniferatoxin reduces ventricular arrhythmias in heart failure via selectively blunting cardiac sympathetic afferent projection into spinal cord in rats. European journal of pharmacology 867, 172836 [PubMed:31811858] [show Abstract] Excessive sympathetic activity is associated with heart failure and ventricular arrhythmias, which regulated by enhanced cardiac sympathetic afferent reflex, which can be blunted by resiniferatoxin, a selective receptor agonist of transient vanilloid potential 1 (TRPV1) + primary sensory afferents. The present study is aimed to determine whether intrathecal resiniferatoxin application affect cardiac sympathetic tone and electrophysiology, furtherly create a new effective strategy to prevent lethal arrhythmias in chronic heart failure. Four weeks after coronary artery occlusion to induce heart failure in rats, RTX (2μg/10 μl) or vehicle was injected intrathecally into the T2/T3 interspace. Cardiac sympathetic nerve activities (CSNA) and cardiac electrophysiology were evaluated two weeks later. Intrathecal resiniferatoxin significantly and selectively abolished the afferent markers expression (TRPV1 and calcitonin gene-related peptide) in dorsal horn and reduced overactivated CSNA. Electrophysiological studies revealed that resiniferatoxin administration intrathecally significantly reversed the prolongation of action potential duration (APD) and APD alternan, reduced the inducibilities of ventricular arrhythmias. Moreover, the over-activated calcium handling related protein CaMKII and RyR2 in heart failure was reversed by resiniferatoxin administration. In conclusion, these results firstly demonstrate that central chemo-ablation of the TRPV1+ afferents in spinal cord prevent heart from ventricular arrhythmias in heart failure via selectively blunting cardiac sympathetic afferent projection into spinal cord, which suggest a novel promising therapeutic method for anti-arrhythmia in heart failure. | Nahama A, Ramachandran R, Cisternas AF, Ji H (2020) The role of afferent pulmonary innervation in ARDS associated with COVID-19 and potential use of resiniferatoxin to improve prognosis: A review. Medicine in drug discovery 5, 100033 [PubMed:32292906] [show Abstract] Acute respiratory distress syndrome (ARDS) is one of the major causes of mortality associated with COVID-19 disease. Many patients will require intensive care with ventilatory support. Despite progress and best efforts, the mortality rates projected remain high. Historical data outlook points towards 80% expected fatality for patients progressing to advanced pulmonary disease, even when hospitalized in the intensive care unit. This is particularly true among the patient population over 65. Novel life-saving strategies are desperately needed to mitigate the high mortality that will be associated with the late stage SARS-CoV-2 viral infection associated with the fatal respiratory distress. We hypothesize that the morbidity, severity of the disease, and underlying physiological events leading to mortality are closely linked to the TRPV1 expressing neuronal system (afferent/efferent neurons) in the lungs. TRPV1 expressing cells are responsible for pain transmission, inflammation and immunomodulation throughout the entire pulmonary system and are modulating the processes associated with localized cytokine release (storm) and overall rapid disease progression. We suggest that therapeutic approaches targeting TRPV1 containing nerve fibers in the lungs will modulate the inflammatory and immune signal activity, leading to reduced mortality and better overall outcomes. We also propose to further explore the use of resiniferatoxin (RTX), an ultra-potent TRPV1 agonist currently in clinical trials for cancer and osteoarthritis pain, as a possible ablating agent of TRPV1 positive pulmonary pathways in patients with advanced COVID-19 disease. | Javed H, Rehmathulla S, Tariq S, Emerald BS, Ljubisavljevic M, Shehab S (2020) Perineural application of resiniferatoxin on uninjured L3 and L4 nerves completely alleviates thermal and mechanical hypersensitivity following L5 nerve injury in rats. The Journal of comparative neurology 528, 2195-2217 [PubMed:32064609] [show Abstract] Fifth lumbar (L5) nerve injury in rats causes neuropathic pain manifested with thermal and mechanical hypersensitivity in the ipsilateral hind paw. This study aimed to determine whether the elimination of unmyelinated primary afferents of the adjacent uninjured nerves (L3 and L4) would alleviate peripheral neuropathic pain. Different concentrations of capsaicin or its analog, resiniferatoxin (RTX), were applied perineurally on either the left L4 or L3 and L4 nerves in Wistar rats whose left L5 nerves were ligated and cut. The application of both capsaicin and RTX on the L4 nerve significantly reduced both thermal and mechanical hypersensitivity. However, only the application of RTX on both L3 and L4 nerves completely alleviated all neuropathic manifestations. Interestingly, responses to thermal and mechanical stimuli were preserved, despite RTX application on uninjured L3, L4, and L5 nerves, which supply the plantar skin in rats. Perineural application of RTX caused downregulation of TRPV1, CGRP, and IB4 binding and upregulation of VIP in the corresponding dorsal root ganglia (DRG) and the dorsal horn of the spinal cord. In comparison, VGLUT1 and NPY immunoreactivities were not altered. RTX application did not cause degenerative or ultrastructural changes in the treated nerves and corresponding DRGs. The results demonstrate that RTX induces neuroplasticity, rather than structural changes in primary afferents, that are responsible for alleviating hypersensitivity and chronic pain. Furthermore, this study suggests that treating uninjured adjacent spinal nerves may be used to manage chronic neuropathic pain following peripheral nerve injury. | Wang D, Wu Y, Chen Y, Wang A, Lv K, Kong X, He Y, Hu N (2019) Focal selective chemo-ablation of spinal cardiac afferent nerve by resiniferatoxin protects the heart from pressure overload-induced hypertrophy. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 109, 377-385 [PubMed:30399572] [show Abstract] Resiniferatoxin (RTX), a selective transient receptor potential vanilloid 1 (TRPV1) receptor agonist, can eliminate TRPV1+ primary sensory afferents and blunt cardiac sympathetic afferent reflex for a relatively long period. The present study determined the effects of intrathecal RTX administration on transverse aortic constriction (TAC)-induced cardiac dysfunction and cardiac remodeling in rats. Five days before TAC, RTX (2 μg/10 μl) was injected intrathecally into the T2/T3 interspace of rats. Cardiac sympathetic nerve activities (CSNAs) and cardiac structure and function were determined eight weeks after TAC. Intrathecal RTX administration abolished TRPV1 expression in the dorsal horn and reduced over-activated CSNA in the TAC rat model. Hemodynamic analysis revealed that RTX reduced left ventricular end-diastolic pressure, indicating the improvement of cardiac compliance. Histologic analysis, real-time reverse transcription-polymerase chain reaction, and Western blots showed that RTX prevented TAC-induced cardiac hypertrophy, cardiac fibrosis, and cardiac apoptosis and reduced the expression of apoptotic proteins and myocardial mRNAs. In conclusion, these results demonstrate that focal chemo-ablation of TRPV1+ afferents in the spinal cord protects the heart from pressure overload-induced cardiac remodeling and cardiac dysfunction, which suggest a novel promising therapeutic method for cardiac hypertrophy and diastolic dysfunction. | Zubcevic L, Hsu AL, Borgnia MJ, Lee SY (2019) Symmetry transitions during gating of the TRPV2 ion channel in lipid membranes. eLife 8, e45779 [PubMed:31090543] [show Abstract] The Transient Receptor Potential Vanilloid 2 (TRPV2) channel is a member of the temperature-sensing thermoTRPV family. Recent advances in cryo-electronmicroscopy (cryo-EM) and X-ray crystallography have provided many important insights into the gating mechanisms of thermoTRPV channels. Interestingly, crystallographic studies of ligand-dependent TRPV2 gating have shown that the TRPV2 channel adopts two-fold symmetric arrangements during the gating cycle. However, it was unclear if crystal packing forces played a role in stabilizing the two-fold symmetric arrangement of the channel. Here, we employ cryo-EM to elucidate the structure of full-length rabbit TRPV2 in complex with the agonist resiniferatoxin (RTx) in nanodiscs and amphipol. We show that RTx induces two-fold symmetric conformations of TRPV2 in both environments. However, the two-fold symmetry is more pronounced in the native-like lipid environment of the nanodiscs. Our data offers insights into a gating pathway in TRPV2 involving symmetry transitions. | Zou J, Dong X, Li Y, Tong S, Wang J, Liao M, Huang G (2019) Deep Sequencing Identification of Differentially Expressed miRNAs in the Spinal Cord of Resiniferatoxin-Treated Rats in Response to Electroacupuncture. Neurotoxicity research 36, 387-395 [PubMed:31124075] [show Abstract] Electroacupuncture (EA) is an effective treatment to relieve pain in patients with postherpetic neuralgia. However, the mechanisms of EA involved therein are still unknown. We first injected resiniferatoxin (RTX) into Sprague Dawley rats to construct the neuralgia model. One week after injection, the rats were treated with EA at the "Huantiao" (GB30) and "Yanglingquan" (GB34) acupoints for 5 weeks. Nociceptive behavioral tests were performed to analyze the changes in thermal sensitivity and mechanical allodynia after RTX induction and EA treatment. Deep sequencing was performed to identify differentially expressed miRNAs in the spinal cord of RTX-induced rats in response to EA treatment. The nociceptive behavioral tests showed that EA at the left GB30 and GB34 acupoints significantly reduced RTX-induced tactile sensitivity and increased RTX-inhibited thermal sensitivity. The sequencing data indicated that RTX resulted in one upregulated and five downregulated miRNAs, and EA treatment resulted in two upregulated miRNAs. Furthermore, seven upregulated and two downregulated miRNAs were found between rats subjected to EA and sham operation. Functional analysis suggested that the targets of differentially expressed miRNAs were enriched in many nervous system-related pathways. The pathway-gene-miRNA net analysis showed that miR-7a-5p had the most target genes. Moreover, miR-233-3p was downregulated after RTX injection and upregulated by EA treatment. We speculated that the upregulation of miR-7a-5p and miR-233-3p is involved in the analgesic effects of EA. Our analysis on the EA-induced differential expression of miRNAs provides novel insights into the mechanisms of EA analgesia in postherpetic neuralgia. | Oliveira R, Coelho A, Franquinho F, Sousa MM, Cruz F, D Cruz C (2019) Effects of early intravesical administration of resiniferatoxin to spinal cord-injured rats in neurogenic detrusor overactivity. Neurourology and urodynamics 38, 1540-1550 [PubMed:31180583] [show Abstract]
ObjectivesTo investigate if intravesical administration during spinal shock of resiniferatoxin (RTX), an ultrapotent desensitizing agonist of transient receptor potential vanilloid-1 (TRPV1), would silence TRPV1-expressing bladder afferents at an early stage of disease progression and modulate neurogenic detrusor overactivity (NDO) emergence.Materials and methodsRats submitted to largely incomplete spinal cord transection at T8/9 spinal segment were treated with intravesical RTX (50 nM) or its vehicle during spinal shock. Four weeks after spinal lesion, bladder-reflex activity was evaluated by cystometry under urethane anesthesia, after which the bladder, spinal cord, and dorsal root ganglia were collected and processed.ResultsWe found improvements on bladder function several weeks after early intravesical RTX administration, including a marked decrease of intravesical pressures and amplitude of bladder contractions. Such strong long-lasting urodynamic effects resulted from the very potent desensitizing activity of RTX on peripheral terminals of sensory afferents, an effect restricted to the bladder.ConclusionOur results support that an early intervention with RTX could potentially attenuate NDO development and ensuing urinary incontinence, with a dramatic impact on the quality of life of spinal cord injury patients. | Unger MD, Pleticha J, Steinauer J, Kanwar R, Diehn F, LaVallee KT, Banck MS, Jones B, Yaksh TL, Maus TP, Beutler AS (2019) Unilateral Epidural Targeting of Resiniferatoxin Induces Bilateral Neurolysis of Spinal Nociceptive Afferents. Pain medicine (Malden, Mass.) 20, 897-906 [PubMed:30590777] [show Abstract]
ObjectiveThis study modeled image-guided epidural drug delivery to test whether intraprocedural distribution of pre-injected contrast reliably predicts the neuroanatomical reach of resiniferatoxin-mediated nociceptive neurolysis.MethodsSwine (N = 12) received unilateral L4-S2 computed tomography fluoroscopy injections by a blinded neuroradiologist; 0.25 mL of contrast was pre-injected to confirm dorsal periganglionic targeting, followed by a 0.5-mL injection of 5 µg of resiniferatoxin/Tween80 or vehicle control. Epidural contrast distribution was graded according to maximum medial excursion. Spinal cord substance P immunostaining quantified the magnitude and anatomical range of resiniferatoxin activity.ResultsPeriganglionic injection was well tolerated by all animals without development of neurological deficits or other complications. Swine were a suitable model of human clinical spinal intervention. The transforaminal approach was used at all L4 and 50% of L5 segments; the remaining segments were approached by the interlaminar route. All injections were successful with unilateral contrast distribution for all resiniferatoxin injections (N = 28). Immunohistochemistry showed bilateral ablation of substance P+ fibers entering the spinal cord of all resiniferatoxin-treated segments. The intensity of substance P immunostaining in treated segments fell below the lower 99% confidence interval of controls, defining the knockout phenotype. Substance P knockout occurred over a narrow range and was uncorrelated to the anatomical distribution of pre-injected contrast.ConclusionsPeriganglionic resiniferatoxin/Tween80 induced bilateral ablation of spinal cord substance P despite exclusively unilateral targeting. These data suggest that the location of pre-injected contrast is an imperfect surrogate for the neuroanatomical range of drugs delivered to the dorsal epidural compartment that may fail to predict contralateral drug effects. | Raithel SJ, Sapio MR, LaPaglia DM, Iadarola MJ, Mannes AJ (2018) Transcriptional Changes in Dorsal Spinal Cord Persist after Surgical Incision Despite Preemptive Analgesia with Peripheral Resiniferatoxin. Anesthesiology 128, 620-635 [PubMed:29271803] [show Abstract]
BackgroundPeripheral nociceptors expressing the ion channel transient receptor potential cation channel, subfamily V, member 1, play an important role in mediating postoperative pain. Signaling from these nociceptors in the peri- and postoperative period can lead to plastic changes in the spinal cord and, when controlled, can yield analgesia. The transcriptomic changes in the dorsal spinal cord after surgery, and potential coupling to transient receptor potential cation channel, subfamily V, member 1-positive nociceptor signaling, remain poorly studied.MethodsResiniferatoxin was injected subcutaneously into rat hind paw several minutes before surgical incision to inactivate transient receptor potential cation channel, subfamily V, member 1-positive nerve terminals. The effects of resiniferatoxin on postincisional measures of pain were assessed through postoperative day 10 (n = 51). Transcriptomic changes in the dorsal spinal cord, with and without peripheral transient receptor potential cation channel, subfamily V, member 1-positive nerve terminal inactivation, were assessed by RNA sequencing (n = 22).ResultsPeripherally administered resiniferatoxin increased thermal withdrawal latency by at least twofold through postoperative day 4, increased mechanical withdrawal threshold by at least sevenfold through postoperative day 2, and decreased guarding score by 90% relative to vehicle control (P < 0.05). Surgical incision induced 70 genes in the dorsal horn, and these changes were specific to the ipsilateral dorsal horn. Gene induction with surgical incision persisted despite robust analgesia from resiniferatoxin pretreatment. Many of the genes induced were related to microglial activation, such as Cd11b and Iba1.ConclusionsA single subcutaneous injection of resiniferatoxin before incision attenuated both evoked and nonevoked measures of postoperative pain. Surgical incision induced transcriptomic changes in the dorsal horn that persisted despite analgesia with resiniferatoxin, suggesting that postsurgical pain signals can be blocked without preventing transcription changes in the dorsal horn. | Zubcevic L, Le S, Yang H, Lee SY (2018) Conformational plasticity in the selectivity filter of the TRPV2 ion channel. Nature structural & molecular biology 25, 405-415 [PubMed:29728656] [show Abstract] Transient receptor potential vanilloid (TRPV) channels are activated by ligands and heat and are involved in various physiological processes. In contrast to the architecturally related voltage-gated cation channels, TRPV1 and TRPV2 subtypes possess another activation gate at the selectivity filter that can open widely enough to permeate large organic cations. Despite recent structural advances, the mechanism of selectivity filter gating and permeation for both metal ions and large molecules by TRPV1 or TRPV2 is not well known. Here, we determined two crystal structures of rabbit TRPV2 in its Ca2+-bound and resiniferatoxin (RTx)- and Ca2+-bound forms, to 3.9 Å and 3.1 Å, respectively. Notably, our structures show that RTx binding leads to two-fold symmetric opening of the selectivity filter of TRPV2 that is wide enough for large organic cation permeation. Combined with functional characterizations, our studies reveal a structural basis for permeation of Ca2+ and large organic cations in TRPV2. | Kan HW, Chang CH, Lin CL, Lee YC, Hsieh ST, Hsieh YL (2018) Downregulation of adenosine and adenosine A1 receptor contributes to neuropathic pain in resiniferatoxin neuropathy. Pain 159, 1580-1591 [PubMed:29672450] [show Abstract] The neurochemical effects of adenosine signaling in small-fiber neuropathy leading to neuropathic pain are yet to be explored in a direct manner. This study examined this system at the level of ligand (through the ectonucleotidase activity of prostatic acid phosphatase [PAP]) and adenosine A1 receptors (A1Rs) in resiniferatoxin (RTX) neuropathy, a peripheral neurodegenerative disorder that specifically affects nociceptive nerves expressing transient receptor potential vanilloid type 1 (TRPV1). We conducted immunohistochemistry on dorsal root ganglion (DRG) neurons, high-performance liquid chromatography for functional assays, and pharmacological interventions to alter PAP and A1Rs in mice with RTX neuropathy. In DRG of RTX neuropathy, PAP(+) neurons were reduced compared with vehicle-treated mice (P = 0.002). Functionally, PAP ectonucleotidase activity was consequently reduced (ie, the content of adenosine in DRG, P = 0.012). PAP(+) neuronal density was correlated with the degree of mechanical allodynia, which was reversed by intrathecal (i.t.) lumbar puncture injection of recombinant PAP with a dose-dependent effect. Furthermore, A1Rs were downregulated (P = 0.002), and this downregulation was colocalized with the TRPV1 receptor (31.0% ± 2.8%). Mechanical allodynia was attenuated in a dose-dependent response by i.t. injection of the A1R ligand, adenosine; however, no analgesia was evident when an exogenous adenosine was blocked by A1R antagonist. This study demonstrated dual mechanisms of neuropathic pain in TRPV1-induced neuropathy, involving a reduced adenosine system at both the ligand (adenosine) and receptor (A1Rs) levels. | Iadarola MJ, Sapio MR, Raithel SJ, Mannes AJ, Brown DC (2018) Long-term pain relief in canine osteoarthritis by a single intra-articular injection of resiniferatoxin, a potent TRPV1 agonist. Pain 159, 2105-2114 [PubMed:30015705] [show Abstract] The translational potential of analgesic approaches emerging from basic research can be augmented by client-owned dog trials. We report on a peripheral interventional approach that uses intra-articular injection of the ultrapotent TRPV1 agonist resiniferatoxin (RTX) to produce a selective long-term chemoinactivation of nociceptive primary afferent nerve endings for pain control in naturally occurring canine osteoarthritis. A single injection of 10 µg of RTX, produced suppression of pain, improvement in gait, weight bearing, and improvement in the dog's activities of daily living lasting 4 months or longer. Two to 3 years after the injection, there are no alterations to suggest that removal of inflammatory pain caused accelerated joint degeneration (Charcot joint) in any of the dogs. To amplify the effective use of canine subjects in translational analgesia research, we report a high-quality canine dorsal root ganglion transcriptome. Some targets for analgesia are highly conserved both in protein sequence and level of expression within a target tissue while others diverge substantially from the human. This knowledge is especially important for development of analgesics aimed at peripheral molecular targets and provides a template for informed translational research. The peripheral site of action, long duration of analgesia, apparent safety, and retention of coordination, all resulting from a single dose suggest that intra-articular RTX may be an effective intervention for osteoarthritis pain with few or no side effects and lead to an improved quality of life. | Hockman TM, Cisternas AF, Jones B, Butt MT, Osborn KG, Steinauer JJ, Malkmus SA, Yaksh TL (2018) Target engagement and histopathology of neuraxial resiniferatoxin in dog. Veterinary anaesthesia and analgesia 45, 212-226 [PubMed:29361418] [show Abstract]
ObjectiveTo evaluate target engagement of intracisternally (IC) delivered TRPV1 agonist, resiniferatoxin (RTX), as measured by primary afferent and dorsal horn substance P immunoreactivity (sP-IR), histopathology and thermal escape latencies in dogs.Study designProspective experimental trial.AnimalsFourteen adult male Beagle dogs, weighing 10.3-13.2 kg; 11 dogs surviving to scheduled euthanasia.MethodsAnesthetized dogs were randomly assigned to be administered IC RTX (3.6 μg, 0.1 mL kg-1) in a hyperbaric (hRTX, n = 6), normobaric (nRTX, n = 4) vehicle or a hyperbaric vehicle (hVehicle, n = 4). Over 16 days, animals were examined for thoracic and pelvic limb paw thermal withdrawal latencies and neurologic function. Spinal cords, trigeminal ganglia and dorsal root ganglia (DRGs) were assessed for morphologic changes and sP-IR.ResultsIC RTX in anesthetized dogs resulted in a < 1 hour increase in blood pressure. Acute reactions leading to euthanasia within 8 hours occurred in three dogs (two hRTX, one nRTX). All other animals recovered with normal neurologic, bowel and bladder function. Final groups were: vehicle n = 4, hRTX n = 4 and nRTX n = 3. Animals in nRTX and hRTX showed increases in escape latencies in thoracic paws and, to a lesser extent, in pelvic paws, correlating to a loss of sP-IR in cervical cord with smaller reductions in thoracic and lumbar cord. In animals surviving to euthanasia, thickening of the arachnoid membrane (predominantly in the cervical region) was the most consistent change. This change, present in controls, was interpreted to be vehicle related. There was no evidence of structural changes in brain and spinal cord.Conclusions and clinical relevanceIC RTX produced localized loss of spinal and DRG sP with a corresponding thermal analgesia, absent motor impairment or spinal pathology. Loss of three animals emphasizes the need to refine the use of this promising therapeutic modality in managing companion animal pain. | Hashimoto S, Katoh SI, Kato T, Urabe D, Inoue M (2017) Total Synthesis of Resiniferatoxin Enabled by Radical-Mediated Three-Component Coupling and 7-endo Cyclization. Journal of the American Chemical Society 139, 16420-16429 [PubMed:29041773] [show Abstract] Resiniferatoxin (1) belongs to a daphnane diterpenoid family and has strong agonistic effects on TRPV1, a transducer of noxious temperature and chemical stimuli. The densely oxygenated trans-fused 5/7/6-tricarbocycle (ABC-ring) of 1 presents a daunting challenge for chemical synthesis. Here we report the development of a novel radical-based strategy for assembling 1 from three components: A-ring 9, allyl stannane 18b, and C-ring 17b. The 6-membered 17b, prepared from d-ribose derivative 19, was designed to possess the caged orthoester structure with α-alkoxy selenide as a radical precursor. Upon treatment of 17b with 18b, 9, and V-40, the potently reactive α-alkoxy bridgehead radical was generated from 17b and then sequentially coupled with 9 and 18b to yield 16b. This first radical reaction formed the hindered C9,10-linkage between the A and C-rings and extended the C4-chain on the A-ring in a stereoselective fashion. After derivatization of 16b into 15, the remaining 7-membered B-ring was cyclized in the presence of n-Bu3SnH and V-40 by utilizing the xanthate on the C-ring as the radical precursor and the allylic dithiocarbonate as the terminator. The second radical reaction thus enabled not only the 7-endo cyclization but also construction of the C8-stereocenter and the C6-exo olefin. Tricycle 14 was elaborated into the targeted 1 by a series of highly optimized chemoselective reactions. The present total synthesis of 1 demonstrates the advantages of radical reactions for linking hindered bonds within carbocycles without damaging preexisting functionalities, thereby offering a new strategic design for multistep target-oriented synthesis. | Muñoz-Carrillo JL, Muñoz-López JL, Muñoz-Escobedo JJ, Maldonado-Tapia C, Gutiérrez-Coronado O, Contreras-Cordero JF, Moreno-García MA (2017) Therapeutic Effects of Resiniferatoxin Related with Immunological Responses for Intestinal Inflammation in Trichinellosis. The Korean journal of parasitology 55, 587-599 [PubMed:29320813] [show Abstract] The immune response against Trichinella spiralis at the intestinal level depends on the CD4+ T cells, which can both suppress or promote the inflammatory response through the synthesis of diverse cytokines. During the intestinal phase, the immune response is mixed (Th1/Th2) with the initial predominance of the Th1 response and the subsequent domination of Th2 response, which favor the development of intestinal pathology. In this context, the glucocorticoids (GC) are the pharmacotherapy for the intestinal inflammatory response in trichinellosis. However, its therapeutic use is limited, since studies have shown that treatment with GC suppresses the host immune system, favoring T. spiralis infection. In the search for novel pharmacological strategies that inhibit the Th1 immune response (proinflammatory) and assist the host against T. spiralis infection, recent studies showed that resiniferatoxin (RTX) had anti-inflammatory activity, which decreased the serum levels of IL-12, INF-γ, IL-1β, TNF-α, NO, and PGE2, as well the number of eosinophils in the blood, associated with decreased intestinal pathology and muscle parasite burden. These researches demonstrate that RTX is capable to inhibit the production of Th1 cytokines, contributing to the defense against T. spiralis infection, which places it as a new potential drug modulator of the immune response. | Gao Y, Cao E, Julius D, Cheng Y (2016) TRPV1 structures in nanodiscs reveal mechanisms of ligand and lipid action. Nature 534, 347-351 [PubMed:27281200] [show Abstract] When integral membrane proteins are visualized in detergents or other artificial systems, an important layer of information is lost regarding lipid interactions and their effects on protein structure. This is especially relevant to proteins for which lipids have both structural and regulatory roles. Here we demonstrate the power of combining electron cryo-microscopy with lipid nanodisc technology to ascertain the structure of the rat TRPV1 ion channel in a native bilayer environment. Using this approach, we determined the locations of annular and regulatory lipids and showed that specific phospholipid interactions enhance binding of a spider toxin to TRPV1 through formation of a tripartite complex. Furthermore, phosphatidylinositol lipids occupy the binding site for capsaicin and other vanilloid ligands, suggesting a mechanism whereby chemical or thermal stimuli elicit channel activation by promoting the release of bioactive lipids from a critical allosteric regulatory site. | Brown DC (2016) Resiniferatoxin: The Evolution of the "Molecular Scalpel" for Chronic Pain Relief. Pharmaceuticals (Basel, Switzerland) 9, E47 [PubMed:27529257] [show Abstract] Control of chronic pain is frequently inadequate or can be associated with debilitating side effects. Ablation of certain nociceptive neurons, while retaining all other sensory modalities and motor function, represents a new therapeutic approach to controlling severe pain while avoiding off-target side effects. transient receptor potential cation channel subfamily V member 1 (TRPV1) is a calcium permeable nonselective cation channel expressed on the peripheral and central terminals of small-diameter sensory neurons. Highly selective chemoablation of TRPV1-containing peripheral nerve endings, or the entire TRPV1-expressing neuron itself, can be used to control chronic pain. Administration of the potent TRPV1 agonist resiniferatoxin (RTX) to neuronal perikarya or nerve terminals induces calcium cytotoxicity and selective lesioning of the TRPV1-expressing nociceptive primary afferent population. This selective neuroablation has been coined "molecular neurosurgery" and has the advantage of sparing motor, proprioceptive, and other somatosensory functions that are so important for coordinated movement, performing activities of daily living, and maintaining quality of life. This review examines the mechanisms and preclinical data underlying the therapeutic use of RTX and examples of such use for the management of chronic pain in clinical veterinary and human pain states. | Iadarola MJ, Gonnella GL (2013) Resiniferatoxin for Pain Treatment: An Interventional Approach to Personalized Pain Medicine. The open pain journal 6, 95-107 [PubMed:26779292] [show Abstract] This review examines existing preclinical and clinical studies related to resiniferatoxin (RTX) and its potential uses in pain treatment. Like capsaicin, RTX is a vanilloid receptor (TRPV1) agonist, only more potent. This increased potency confers both quantitative and qualitative advantages in terms of drug action on the TRPV1 containing nerve terminal, which result in an increased efficacy and a long duration of action. RTX can be delivered by a central route of administration through injection into the subarachnoid space around the lumbosacral spinal cord. It can also be administered peripherally into a region of skin or deep tissue where primary afferents nerves terminate, or directly into a nerve trunk or a dorsal root ganglion. The central route is currently being evaluated as a treatment for intractable pain in patients with advanced cancer. Peripheral administration offers the possibility to treat a wide diversity of pain problems because of the ability to bring the treatment to the site of the pain (the peripheral generator). While not all pain disorders are appropriate for RTX, tailoring treatment to an individual patient's needs via a selective and local intervention that chemically targets a specific population of nerve terminals provides a new capability for pain therapy and a simplified and effective approach to personalized pain medicine. | Szallasi A, Blumberg PM (1989) Resiniferatoxin, a phorbol-related diterpene, acts as an ultrapotent analog of capsaicin, the irritant constituent in red pepper. Neuroscience 30, 515-520 [PubMed:2747924] [show Abstract] Resiniferatoxin is an extremely irritant diterpene present in the latex of several members of the genus Euphorbia. Its mechanism of action has been shown to be clearly distinct from that of the structurally related phorbol esters. Since resiniferatoxin possesses a 4-hydroxy-3-methoxyphenyl substituent, a key feature of capsaicin, the major pungent ingredient of plants of the genus Capsicum, we examined the ability of resiniferatoxin to induce typical capsaicin responses. We report here that treatment of rats with resiniferatoxin, like treatment with capsaicin, caused hypothermia, neurogenic inflammation, and pain. These responses were followed by loss of thermoregulation, by desensitization to neurogenic inflammation, and by chemical and thermal analgesia, with cross-tolerance between resiniferatoxin and capsaicin. Resiniferatoxin was 3 4 orders of magnitude more potent than capsaicin for the effects on thermoregulation and neurogenic inflammation. Resiniferatoxin was only comparable in potency to capsaicin, however, in the assay for induction of acute pain, and the desensitization to acute pain appeared to require less resiniferatoxin than did desensitization for the other responses. We conclude that resiniferatoxin acts as an ultrapotent capsaicin analog and hypothesize that it may distinguish between subclasses of capsaicin response. | Driedger PE, Blumberg PM (1980) Different biological targets for resiniferatoxin and phorbol 12-myristate 13-acetate. Cancer research 40, 1400-1404 [PubMed:7189445] [show Abstract] The phorbol-related diterpene ester resiniferatoxin is at least 100-fold more inflammatory for the mouse ear than is the potent tumor promoter phorbol 12-myristate 13-acetate but is nonpromoting. We report here that resiniferatoxin is 100- to 1000-fold less active than is phorbol 12-myristate 13-acetate in in vitro assays with both chicken and mouse fibroblasts. These results suggest that resiniferatoxin and phorbol 12-myristate 13-acetate have different primary target sites (receptors) and provide further evidence that the fibroblast target may be homologous to that involved in promotion. |
|